MedPath

Compliance With Once Daily Glaucoma Medication

Completed
Conditions
Compliance
Interventions
Behavioral: Intervention
Registration Number
NCT00333463
Lead Sponsor
Alcon Research
Brief Summary

A study to examine patient compliance with once daily glaucoma medication

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
700
Inclusion Criteria
  • Primary open angle glaucoma or ocular hypertension patients
Exclusion Criteria
  • None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Intervention groupInterventionThe intervention group watched an educational video, reviewed current barriers to drop-taking and possible solutions with a study coordinator, received regular phone call reminders, and had audible and visible reminders activated on their DA devices.
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ft. Worth

🇺🇸

Ft. Worth, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath